Updated pregnancy outcomes from the teriflunomide clinical development programme: retrospective analysis of the teriflunomide clinical trial database

被引:0
|
作者
Kieseier, B. [1 ]
Stueve, O. [2 ]
Benamor, M. [3 ]
Delhay, J. [3 ]
Truffinet, P. [3 ]
机构
[1] Univ Dusseldorf, Dusseldorf, Germany
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Sanofi, Chilly Mazarin, France
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:223 / 224
页数:2
相关论文
共 50 条
  • [41] A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus
    Yao, Xueting
    Wu, Yiwen
    Jiang, Ji
    Chen, Xia
    Liu, Dongyang
    Hu, Pei
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 136
  • [42] PROGESTERONE THERAPY & CLINICAL OUTCOMES IN DIFFUSE AXONAL INJURY: A RETROSPECTIVE ANALYSIS OF DATA FROM THE PROTECTIII TRIAL
    Leary, Owen P.
    Yeatts, Sharon
    Poore, Casey
    Wright, David W.
    Allen, Jason W.
    Pauls, Qi
    Merck, Lisa H.
    JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A247 - A247
  • [43] Pregnancy outcomes during the clinical development programme of cladribine in multiple sclerosis (MS): an integrated analysis of safety for all exposed patients
    Galazka, A.
    Nolting, A.
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Hicking, C.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 997 - 998
  • [44] Efficacy Data from Two Pivotal Teriflunomide Clinical Trials, Including Subgroup Analyses of Patients with High Disease Activity
    Kappos, L.
    Comi, G.
    Freedman, M. S.
    Miller, A. E.
    Olsson, T. P.
    Wolinsky, J. S.
    Truffinet, P.
    Cavalier, S.
    Benamor, M.
    Dukovic, D.
    O'Connor, P.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 933 - 933
  • [45] "NUMBER NEEDED TO TREAT" ANALYSIS TO ASSESS THE COMPARATIVE OUTCOMES FROM TERIFLUNOMIDE AND DIMETHYL FUMARATE STUDIES IN RELAPSING MULTIPLE SCLEROSIS
    Leist, T. P.
    Montalban, X.
    Miller, A. E.
    Dive-Pouletty, C.
    Freedman, M. S.
    VALUE IN HEALTH, 2015, 18 (03) : A279 - A280
  • [46] Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial
    Kappos, Ludwig
    Fox, Robert J.
    Burcklen, Michel
    Freedman, Mark S.
    Havrdova, Eva K.
    Hennessy, Brian
    Hohlfeld, Reinhard
    Lublin, Fred
    Montalban, Xavier
    Pozzilli, Carlo
    Scherz, Tatiana
    D'Ambrosio, Daniele
    Linscheid, Philippe
    Vaclavkova, Andrea
    Pirozek-Lawniczek, Magdalena
    Kracker, Hilke
    Sprenger, Till
    JAMA NEUROLOGY, 2021, 78 (05) : 558 - 567
  • [47] The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review
    Gardiner, Fergus W.
    McCuaig, Ruth
    Arthur, Chris
    Carins, Thomas
    Morton, Adam
    Laurie, Josephine
    Neeman, Teresa
    Lim, Boon
    Peek, Michael J.
    OBSTETRIC MEDICINE, 2019, 12 (03) : 123 - 128
  • [48] Real-world data from the TACO (Teriflunomide in relapsing remitting multiple sclerosis patients assessing clinical benefit and patient-reported outcomes) study
    Gobbi, C.
    Achtnichts, L.
    Derfuss, T.
    Stellmes, P.
    Kamm, C. P.
    Agosti, R.
    Czaplinksi, A.
    Salmen, A.
    Zecca, C.
    Roesch, N.
    Kaiser, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 755 - 755
  • [49] Clinical characteristics and outcomes of extrapulmonary small cell cancer: A retrospective analysis of the SEER database.
    Abdullah, Hafez Mohammad
    Ellithi, Moataz
    Ahmed, Mamoon
    Ali, Lina
    Ali, Mohammad
    Anwer, Faiz
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] ASSESSING THE COMPARATIVE OUTCOMES FROM TERIFLUNOMIDE AND DIMETHYL FUMARATE STUDIES IN RELAPSING MS: USE OF "NUMBER NEEDED TO TREAT" ANALYSIS
    Freedman, M. S.
    Montalban, X.
    Miller, A. E.
    Dive-Pouletty, C.
    Leist, T. P.
    VALUE IN HEALTH, 2014, 17 (07) : A392 - A392